Back
Atara Biotherapeutics Quote, Financials, Valuation and Earnings
Sponsored
ATRA
Sponsored
Do you own any of the "SELL" rated stocks on this list?
Go here now to get free instant access to all 20 stocks to sell.
Sell
20
ATRA
Atara Biotherapeutics
Last Price:
8.03
Seasonality Move:
-9.83%
7 Day Trial
ALL ACCESS PASS
$
7
Wall St Issues Rare "SELL" alert
MarketBeat is making the full list completely FREE for a limited time.Atara Biotherapeutics Price Quote
$8.03
-0.04 (4.83%)
(Updated: September 28, 2024 at 6:19 AM ET)
Atara Biotherapeutics Key Stats
Sell
20
Atara Biotherapeutics (ATRA)
is a Sell
Day range:
$7.61 - $8.39
52-week range:
$4.97 - $45.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.66
P/B ratio:
0%
Volume:
106.8K
Avg. volume:
176.3K
1-year change:
-78.75%
Market cap:
$45.8M
Revenue:
$8.6M
EPS:
$-39.35
How Much Does Atara Biotherapeutics Make?
-
How Much Are Atara Biotherapeutics's Sales Annually?
ATRA Revenues are $8.6M -
How Much Profit Does Atara Biotherapeutics's Make A Year?
ATRA net income is -$276.1M
Is Atara Biotherapeutics Growing As A Company?
-
What Is Atara Biotherapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 28.93% -
What Is Atara Biotherapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Atara Biotherapeutics Stock Price Performance
-
Did Atara Biotherapeutics Stock Go Up Last Month?
Atara Biotherapeutics share price went up by 18.06% last month -
Did ATRA's Share Price Rise Over The Last Year?
ATRA share price fell by -78.75% over the past 1 year
What Is Atara Biotherapeutics 52-Week High & Low?
-
What Is Atara Biotherapeutics’s 52-Week High Share Price?
Atara Biotherapeutics has traded as high as $45.75 over the past 52 weeks -
What Is Atara Biotherapeutics’s 52-Week Low Share Price?
Atara Biotherapeutics has traded as low as $4.97 over the past 52 weeks
Atara Biotherapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Atara Biotherapeutics?
-
How Much Debt Does Atara Biotherapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Atara Biotherapeutics Have?
Cash and short term investments quarterly total is $35.3M -
What Is Atara Biotherapeutics’s Book Value Per Share?
Book value per share is -22.61
Is Atara Biotherapeutics Cash Flow Positive?
-
What Is ATRA Cash Flow From Operations?
Cash flow from operations (TTM) is -$142M -
What Is Atara Biotherapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $25.1M -
What Is Atara Biotherapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $102.3M
Atara Biotherapeutics Return On Invested Capital
Data Unavailable
Atara Biotherapeutics Earnings Date & Stock Price
-
What Is Atara Biotherapeutics's Stock Price Today?
A single share of ATRA can be purchased today for 8.08 -
What Is Atara Biotherapeutics’s Stock Symbol?
Atara Biotherapeutics trades on the nasdaq under the ticker symbol: ATRA -
When Is Atara Biotherapeutics’s Next Earnings Date?
The next quarterly earnings date for Atara Biotherapeutics is scheduled on November 1, 2024 -
When Is ATRA's next ex-dividend date?
Atara Biotherapeutics's next ex-dividend date is September 28, 2024 -
How To Buy Atara Biotherapeutics Stock?
You can buy Atara Biotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Atara Biotherapeutics Competitors
-
Who Are Atara Biotherapeutics's Competitors?
Below is a list of companies who compete with Atara Biotherapeutics or are related in some way:
Atara Biotherapeutics Dividend Yield
-
What Is ATRA Dividend Yield?
Atara Biotherapeutics’s dividend yield currently is 0% -
What Is Atara Biotherapeutics’s Payout Ratio?
Atara Biotherapeutics’s payout ratio is 0% -
When Did Atara Biotherapeutics Last Pay A Dividend?
The latest dividend pay date is September 28, 2024 -
What Is Atara Biotherapeutics’s Dividend Per Share?
Atara Biotherapeutics pays a dividend of $0.00 per share
Atara Biotherapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -38.52% |
Revenue: | 2892.69% | -22.79% |
Analyst Recommendations
Buy Recommendations: | 3 |
---|---|
Hold Recommendations: | 3 |
Sell Recommendations: | 0 |
Price Target: | 90.50 |
Upside from Last Price: | 1020.74% |